A5048451465- Hepatocellular Carcinoma Treatment and Prognosis
- Medical Imaging and Pathology Studies
- Liver Disease Diagnosis and Treatment
- Liver Disease and Transplantation
- Renal cell carcinoma treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Management of metastatic bone disease
- Lung Cancer Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- Bone health and treatments
- Medical Imaging Techniques and Applications
- Organ Transplantation Techniques and Outcomes
- Sarcoma Diagnosis and Treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Renal and related cancers
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- MRI in cancer diagnosis
- Pancreatic and Hepatic Oncology Research
- Radiopharmaceutical Chemistry and Applications
- Pleural and Pulmonary Diseases
- Gastrointestinal Tumor Research and Treatment
- Radiation Dose and Imaging
- Cancer Diagnosis and Treatment
- Liver physiology and pathology
Hyogo University
2022-2024
Hyogo Medical University
2015-2023
Shimane University
2023
Mie University
2009-2022
Weatherford College
2021
Oita Red Cross Hospital
2018
Hokkaido University
2017
Memorial Sloan Kettering Cancer Center
2014-2016
Tsu City College
2012
Oita University
1997-2011
OBJECTIVE. This study retrospectively evaluates complications after lung radiofrequency ablation (RFA).
Purpose: To retrospectively evaluate the long-term results of radiofrequency (RF) ablation combined with chemoembolization (combination therapy) as compared hepatectomy for treatment early-stage hepatocellular carcinoma (HCC). Materials and Methods: The study was approved by institutional review board, informed consent waived. Patients HCC were included if they underwent either combination therapy or met following inclusion criteria: no previous HCC, three fewer tumors a maximum diameter 3...
PURPOSE: To determine the computed tomographic (CT) features of uneven fatty replacement pancreas and clarify their radiologic clinical importance. MATERIALS AND METHODS: CT scans from 80 patients with were reviewed. Uneven was classified into two types. In type 1, posterior aspect head spared intense replacement. 2, focal area around common bile duct (CBD) Each divided subgroups on basis whether body tail showed (type a = negative for replacement, b positive replacement). Findings...
Abstract BACKGROUND: The authors retrospectively evaluated the impact of lung radiofrequency (RF) ablation on survival in patients with metastases from musculoskeletal sarcomas. METHODS: Lung RF was done under real‐time computed tomography (CT) fluoroscopy. Safety, local tumor progression, and were 2 institutions. RESULTS: performed 20 consecutive patients. mean maximum diameter 14 ± 9 mm (range, 5‐40 mm) number 7 6 1‐18) per patient. Pneumothorax requiring chest tube placement developed 24...
Background Although radiofrequency ablation (RFA) is widely performed for the treatment of colorectal cancer (CRC) lung metastases, its efficacy candidates with surgically resectable disease unclear. Purpose To evaluate prognosis after RFA in participants CRC metastases. Materials and Methods For this prospective multicenter study (ClinicalTrials.gov identifier: NCT00776399), five or fewer metastases measuring 3 cm less were included. Participants a total 100 0.4-2.8 (mean, 1.0 ± 0.5) chosen...
To compare clinical outcomes of radiofrequency (RF) ablation retrospectively with those after radical nephrectomy in patients stage T1b renal cell carcinoma (RCC).This retrospective study was approved by the institutional review board, and requirement to obtain written informed consent waived. From June 2002 March 2012, 60 (mean age, 65.2 years; age range, 39-86 years) a single RCC measuring 4.1-7.0 cm (stage T1b) underwent RF (n = 21) or 39). Selective artery embolization performed before...
The purpose of this article is to retrospectively evaluate the frequency and risk factors for complications after liver radiofrequency ablation (RFA).This was a retrospective study 656 patients (with 1755 tumors) who underwent 1500 CT fluoroscopy-guided RFA sessions. Of those patients, 501 had primary tumor 155 metastases. Mortality treatment-related were documented. Complications evaluated according Common Terminology Criteria Adverse Events (version 4.0). Major defined as grade 3 or higher...
Purpose: To evaluate the changes in T-cell balance peripheral blood following percutaneous tumor ablation.Material and methods: Patients underwent thermal ablation including radiofrequency (n = 9) microwave 5), or cryoablation 5). Target tumors were located lung 7), soft tissue liver 4), bone 3). Patient samples collected before within 14 days after ablation. Peripheral populations of cytotoxic T-cells (CTL), type-1 (Th1) type-2 helper (Th2), regulatory (Treg) measured using flow cytometry....
The purpose of this study was to evaluate the clinical utility adrenal radiofrequency ablation combined with arterial chemoembolization in treatment patients metastasis hepatocellular carcinoma.This retrospective conducted at two institutions. Adrenal and were performed on same day. Safety, local tumor progression, survival evaluated.Six eight metastatic lesions treated. mean maximum diameter 5.2 +/- 1.8 cm (range, 3.5-8.0 cm). During initial combination therapy, an lesion isolated one...
To evaluate the clinical utility of lung radiofrequency ablation (RFA) in patients with unresectable pulmonary metastasis from renal cell carcinoma (RCC).We retrospectively examined 39 metastases RCC who were treated RFA. Patients six or fewer measuring < =6 cm that confined lung, had all tumours ablated (curative ablation). extrapulmonary lesions, seven more tumours, large >6 cm, mass reduction (palliative The primary endpoints was overall survival, secondary safety, local tumour...
Radiofrequency Ablation for the Treatment of Bone Metastases From Hepatocellular CarcinomaMasataka Kashima1, Koichiro Yamakado1, Haruyuki Takaki1, Toshio Kaminou2, Noboru Tanigawa3, Atsuhiro Nakatsuka1 and Kan Takeda1Audio Available | Share